DuPont reported a 48% increase in adjusted EPS to $1.88 for Q2 2026, despite a slight stock dip. The company raised its full-year guidance while Wells Fargo maintained an overweight rating with a $166
DuPont shares rose 0.78% to close at $130.02 on September 22, outperforming the S&P 500 with high volume ahead of the US session.
DuPont de Nemours Inc shares rose 2.27% following a TradingKey analysis citing stable fundamentals and high institutional ownership. Analysts issued Buy ratings with a $166.36 target price, predicting
DuPont reported mixed Q1 2026 earnings with a slight revenue decline but higher adjusted EPS due to cost control and portfolio reshaping. It reaffirmed full-year guidance focusing on specialty materia
DuPont de Nemours reported Q1 2025 earnings surpassing analyst expectations with EPS of $22.56 and revenue of $53.53 billion.
DuPont de Nemours beat Q1 2025 estimates with $1.29 EPS and $3.07 billion revenue, surpassing consensus figures. The company has announced its next earnings date for August 4, 2026.
DuPont de Nemours reported Q3 2025 earnings beating consensus with an EPS of $3.27 against $1.40 expectations. Revenue totaled $3.07 billion, though year-over-year growth decreased by 3.76%.
DuPont de Nemours beat Q1 2026 EPS and revenue expectations, raising full-year guidance despite raw material cost headwinds, driven by strong performance in Healthcare & Water and Diversified Industri
DuPont is set to release Q2 2026 earnings with analysts projecting a 47.6% year-over-year EPS decline to $1.76. Despite facing lawsuits over forever chemicals, analysts maintain a Strong Buy rating ci
DuPont de Nemours reported Q1 earnings of 1.43 EUR per share and revenue of 1.45 billion EUR, both surpassing analyst expectations. Future projections indicate continued growth with anticipated EPS of
DuPont de Nemours stock outperformed the Nasdaq with 17.1% YTD gains, driven by Q1 net sales up 4.3% and adjusted EPS rising 52.8%. Analysts maintain a "Strong Buy" rating with a 20.1% upside potentia
DuPont de Nemours announced its 2026 adjusted EPS guidance, projecting a range between $7.02 and $7.16. This financial outlook provides investors with insight into the company's expected earnings perf
DuPont de Nemours Inc. shares rose 2.06% to $48.12 on Friday, outperforming the broader market indices including the S&P 500 and Dow Jones Industrial Average.
DuPont shares fell 4.28% to $46.56 on Tuesday, marking four consecutive days of losses amid a broader market decline affecting major indices.
DuPont de Nemours reported better-than-expected Q1 earnings while continuing to streamline its portfolio toward high-margin specialty materials. The company aims to focus on growth areas like advanced
DuPont de Nemours reported Q1 2026 adjusted EPS of $0.55, beating estimates, with net sales rising 4%. The positive results and raised guidance triggered an 8.4% stock surge, driven by growth in elect
DuPont de Nemours reported mixed Q1 2026 results, beating earnings but missing revenue. Volatile raw material costs remain key risks despite progress in specialty segments like Electronics & Industria
DuPont de Nemours reported Q1 2026 EPS of $0.55, beating estimates, while revenue reached $1.68 billion despite a 45.17% year-over-year decline.
DuPont de Nemours exceeded Q1 2026 guidance with 2% organic sales growth and raised its full-year outlook. It also completed an aramids business divestiture and announced a $275 million share repurcha
DuPont de Nemours reported Q1 2026 net sales of $1.68 billion, up 4% YoY, with adjusted EPS rising 53%. The company completed its Aramids divestiture and raised full-year guidance amid strong performa
DuPont exceeded Q1 2026 guidance with $1.7B sales and 53% EPS growth, raising full-year outlook after divesting its Aramids business and announcing a $275M buyback.
ChemBrief